Literature DB >> 18620773

Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey.

Kiyoshi Hasegawa1, Masatoshi Makuuchi, Tadatoshi Takayama, Norihiro Kokudo, Shigeki Arii, Masatoshi Okazaki, Kiwamu Okita, Masao Omata, Masatoshi Kudo, Masamichi Kojiro, Yasuni Nakanuma, Kenichi Takayasu, Morito Monden, Yutaka Matsuyama, Iwao Ikai.   

Abstract

BACKGROUND/AIMS: The treatment of choice for HCC remains controversial. We evaluated the therapeutic impact of surgical resection, PEI, and RFA for HCC on outcomes.
METHODS: A database derived from a Japanese nationwide survey of 17,149 patients with HCC treated by resection, PEI, or RFA between 2000 and 2003 was used to identify 7185 patients with no more than 3 tumors (< or = 3 cm) and a liver function of Child-Pugh class A or B. The patients classified into either a resection (n=2857), RFA (n=3022), or PEI group (n=1306) and their long-term outcomes were compared.
RESULTS: The median follow-up period was 10.4 months. The 2-year time-to-recurrence rate was 35.5%, 55.4%, and 73.3% in the resection, RFA, and PEI groups, respectively, while the number of recurrences was 2410, 2368, and 862. Although the number of deaths was 55 (1.9%), 49 (1.6%), and 39 (3.0%), the overall survival rates were not different. In a multivariate analysis, surgical resection was a significant negative factor for recurrence as compared with RFA (relative risk, 0.62 [95% confidence interval, 0.54-0.71], P<0.0001) and PEI (0.45 [0.38-0.52], P<0.0001).
CONCLUSIONS: This preliminary report suggested that surgical resection may provide less time-to-recurrence rate than either RFA or PEI in patients with HCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18620773     DOI: 10.1016/j.jhep.2008.05.018

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  39 in total

Review 1.  Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies.

Authors:  Gianpiero Gravante; John Overton; Roberto Sorge; Neil Bhardwaj; Matthew S Metcalfe; David M Lloyd; Ashley R Dennison
Journal:  J Gastrointest Surg       Date:  2011-02       Impact factor: 3.452

2.  Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma.

Authors:  Hung-Hsu Hung; Chien-Wei Su; Chiung-Ru Lai; Gar-Yang Chau; Che-Chang Chan; Yi-Hsiang Huang; Teh-Ia Huo; Pui-Ching Lee; Wei-Yu Kao; Shou-Dong Lee; Jaw-Ching Wu
Journal:  Hepatol Int       Date:  2010-09-24       Impact factor: 6.047

3.  Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients.

Authors:  Jia-yan Ni; Lin-feng Xu; Hong-liang Sun; Jing-xing Zhou; Yao-ting Chen; Jiang-hong Luo
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-26       Impact factor: 4.553

Review 4.  Hepatocellular carcinoma review: current treatment, and evidence-based medicine.

Authors:  Ali Raza; Gagan K Sood
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

5.  What liver surgeons have achieved in the recent decade for patients with hepatocellular carcinoma?

Authors:  Takashi Kokudo; Norihiro Kokudo
Journal:  Glob Health Med       Date:  2020-10-31

6.  Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan.

Authors:  Masatoshi Kudo; Namiki Izumi; Michiie Sakamoto; Yutaka Matsuyama; Takafumi Ichida; Osamu Nakashima; Osamu Matsui; Yonson Ku; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Liver Cancer       Date:  2016-05-10       Impact factor: 11.740

7.  Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation.

Authors:  Won Kyoung Yun; Moon Seok Choi; Dongil Choi; Hyun-Chul Rhim; Jae Won Joh; Kyung Hee Kim; Tae Hoon Jang; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Hepatol Int       Date:  2010-12-25       Impact factor: 6.047

Review 8.  Surgical approach for hepatitis C virus-related hepatocellular carcinoma.

Authors:  Junichi Shindoh; Masaji Hashimoto; Goro Watanabe
Journal:  World J Hepatol       Date:  2015-01-27

Review 9.  From minimal to maximal surgery in the treatment of hepatocarcinoma: A review.

Authors:  Marcos Vinicius Perini; Graham Starkey; Michael A Fink; Ramesh Bhandari; Vijayaragavan Muralidharan; Robert Jones; Christopher Christophi
Journal:  World J Hepatol       Date:  2015-01-27

10.  Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes.

Authors:  Hiroki Nishikawa; Yukio Osaki; Eriko Iguchi; Haruhiko Takeda; Fumihiro Matsuda; Jun Nakajima; Azusa Sakamoto; Keiichi Hatamaru; Sumio Saito; Akihiro Nasu; Ryuichi Kita; Toru Kimura
Journal:  J Gastroenterol       Date:  2012-10-12       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.